FDA Approves H1N1 Vaccines

  Good news: The vaccine for seasonal flu is available now!


Printable Materials for Promoting Good Health Habits

Cover Your Cough
Be a Germ Stopper: Healthy Habits Keep You Well
Flu Prevention Toolkit: Real People. Real Solutions
Stopping the Spread of Germs at Home, Work & School

More information

The most current information on the H1N1 flu can be found at the CDC Web site: www.cdc.gov. The County of San Diego website: www.sdcounty.ca.gov or by calling 211.

  Pandemic Influenza
  Questions About Flu Shots?
  Kids Are In Danger With Cough and Cold Medications

Children and flu vaccine

  Over the Counter Cold Medicines
  FLU OTC Cold Medicine recommendations from The American Academy of Pediatrics
  Asthma Management
  Manage Your Asthma and Score
  COPD Chronic Bronquitis








....The Food and Drug Administration approved the pandemic H1N1 influenza vaccine from four different manufacturers, clearing the way for the vaccine to be administered as soon as enough of it is available. The approval was announced to Congress by Health and Human Services Secretary Kathleen INFLUENZA VACCINESSebelius.

The vaccines will be distributed nationally after the initial lots become available, which is expected within the next four weeks.Potential side effects of the H1N1 vaccines are expected to be similar to those of seasonal flu vaccines. People with severe or life-threatening allergies to chicken eggs, or to any other substance in the vaccine, should not be vaccinated.

For the injected vaccine, the most common side effect is soreness at the injection site. Other side effects may include mild fever, body aches, and fatigue for a few days after the inoculation. For the nasal spray vaccine, the most common side effects include runny nose or nasal congestion for all ages, sore throats in adults, and -- in children 2 to 6 years old -- fever.

As with any medical product, unexpected or rare serious adverse events may occur. The FDA is working closely with governmental and nongovernmental organizations to enhance the capacity for adverse event monitoring, information sharing and analysis during and after the 2009 H1N1 vaccination program. In the U.S. Department of Health and Human Services, these agencies include the Centers for Disease Control and Prevention.

Officials from the National Institute of Allergy and Infectious Diseases announced Friday that the vaccine was safe and produced adequate immunity with only one dose. Researchers had feared that two doses would be required, limiting the amount of vaccine available and complicating the logistics for delivering it.

The United States has ordered enough vaccine for 195 million doses, meaning that "We will have enough vaccine available for everyone," Sebelius said. About 45 million doses are expected to be available by the middle of October, and officials are targeting those in the highest-risk groups -- primarily pregnant women and healthcare workers. Many people fear the vaccine because of its supposed "experimental" nature and perceived safety issues, but government scientists note that it is virtually identical to the seasonal flu vaccine, which has been given safely to hundreds of millions of people.




TEL- 619-427-4111 Email - Health@infooption.com

Salud+HealthInfo is for information and educational purposes only. You should not rely on this information as a substitute for personal medical attention, diagnosis or hands-on treatment. If you are concerned abut your health or that of a child, please consult your family's physician or health provider immediately and do not try to diagnose yourself.

Copyright 2001-2009 Info Option Network

About Us | Privacy Policy | Disclaimer | Contact Us